About Isobionics
Isobionics is a Healthcare company based in Geleen (Netherlands) founded in 2008, and was acquired by BASF in September 2019. Natural flavor and fragrance compounds are produced via fermentation. Isobionics offers products and services including Natural beta-Caryophyllene 80 and Citrus Flavor Ingredients. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified.
Company details
Isobionics was founded in 2008 in Geleen, Netherlands, and operates within the food, beverage, flavor, and fragrance sectors. Proprietary fermentation technology is utilized, starting with sucrose to generate complex natural compounds. Products such as valencene for citrus flavors, nootkatone from grapefruit peel, beta-elemene from ginger roots, sandalwood oil, and patchouli oil are manufactured for market applications.
- Headquarters Geleen, Netherlands
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website isobionics.com/global/en
- Social LinkedIn
- Acquired by BASF (Sep 2019)
- Latest Funding Round$332.74K (USD), Grant
Sep 2023
- Investorsdsm-firmenich
& 4 more
- Acquired byBASF
(Sep 2019)
Products & Services of Isobionics
Isobionics offers a comprehensive portfolio of products and services, including Natural beta-Caryophyllene 80 and Citrus Flavor Ingredients.
Natural compound for enhancing flavors in food and beverages.
Range of citrus-based flavors from renewable sources for various applications.
Funding Insights of Isobionics
- Total Rounds 3
- Last Round Grant — $332,743
- Investors Count 4
All 3 funding rounds of Isobionics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $332,743 | Grant | – | – | |
| Mar 2014 | Series C | – | – | ||
| Jun 2008 | Seed | – | Brightlands Venture Partners | – |
5 investors in total: 5 institutional.
Investors in Isobionics
Isobionics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include dsm-firmenich, BASF and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life-Sciences & Offline focused VC firm funding companies in Netherlands | vanherkgroep.nl | Rotterdam, Netherlands | ||
Brightlands Venture Partners is focused on venture capital investments. | brightlandsventurepartners.com | Geleen, Netherlands | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Health, nutrition, and bioscience solutions are delivered worldwide. | 1902 | dsm.com | Heerlen, Netherlands | |
Chemicals and related products are produced and marketed globally. | 1865 | basf.com | Florham Park, United States |
Investor details for Isobionics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Isobionics
4 dated milestones of Isobionics across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Isobionics is founded.
- Funding First funding round.
- Exit Acquired by BASF.
- Funding Latest funding round, Grant, of $333K.
Web traffic of Isobionics
The website of Isobionics (isobionics.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 35.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Isobionics
Complete news archive for Isobionics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Isobionics
Isobionics was founded in 2008.
Isobionics is headquartered in Geleen, Netherlands. It is registered at Geleen, Limburg, Netherlands.
Isobionics was founded in 2008 in Geleen, Netherlands, and operates within the food, beverage, flavor, and fragrance sectors. Proprietary fermentation technology is utilized, starting with sucrose to generate complex natural compounds. Products such as valencene for citrus flavors, nootkatone from grapefruit peel, beta-elemene from ginger roots, sandalwood oil, and patchouli oil are manufactured for market applications.
Isobionics offers Natural beta-Caryophyllene 80 and Citrus Flavor Ingredients.
Isobionics has 5 investors. Key investors include dsm-firmenich, BASF, European Union, Van Herk Groep, and Brightlands Venture Partners.
Yes. Isobionics was acquired by BASF in September 2019.